You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sammons

Showing 1 - 25 of 406
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Nashville, Dallas, Fairfax (JZP898, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Nashville, Tennessee
  • +2 more
Oct 26, 2023

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Advanced Solid Tumor Trial in Australia, United States (Mirdametinib, BGB-3245)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +5 more
Jan 26, 2023

Neuroendocrine Tumors Trial in United States (Surufatinib)

No longer available
  • Neuroendocrine Tumors
  • Denver, Colorado
  • +10 more
Oct 28, 2022

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Tumors Trial in Italy, United States (surufatinib)

Completed
  • Tumors
  • Los Angeles, California
  • +11 more
Jan 11, 2023

DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Aug 22, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Refractory Multiple Myeloma Trial in United States (Lintuzumab AC 225)

Terminated
  • Refractory Multiple Myeloma
  • Lintuzumab AC 225
  • Los Angeles, California
  • +4 more
Feb 22, 2022

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

Active, not recruiting
  • Advanced Solid Tumor
  • +3 more
  • TP-1454 monotherapy
  • TP-1454 combination therapy
  • Phoenix, Arizona
  • +8 more
Nov 18, 2022

Diffuse Large B-cell Lymphoma Trial in United States (Loncastuximab Tesirine, Rituximab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Reno, Nevada
  • +4 more
Jul 1, 2022

Breast Cancer Trial in Dallas (Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis)

Recruiting
  • Breast Cancer
  • Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Oct 7, 2021

Healthy Volunteers, Anemia, Sickle Cell Trial in Spain, United States (AG-946, AG-946 Matched Placebo)

Recruiting
  • Healthy Volunteers
  • Anemia, Sickle Cell
  • La Jolla, California
  • +10 more
Jan 19, 2023

Chronic Graft-versus-host-disease Trial in United States (Itacitinib)

Recruiting
  • Chronic Graft-versus-host-disease
  • Denver, Colorado
  • +4 more
Jan 24, 2022

Metastatic Esophageal Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Dallas (Abemaciclib,

Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
Jun 4, 2021

Pancreatic Adenocarcinoma Trial in Dallas (Anakinra)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
Jun 8, 2021

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

Recruiting
  • AML
  • +6 more
  • Gilbert, Arizona
  • +7 more
Jul 8, 2022

Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Recurrent Hepatocellular Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Oct 7, 2022

Pancreatic Adenocarcinoma Trial in Dallas (Nab-paclitaxel, Gemcitabine, Cisplatin)

Completed
  • Pancreatic Adenocarcinoma
  • Dallas, Texas
    Baylor Charles A. Sammons Cancer Center
Jun 21, 2021

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Solid Tumor Trial in United States (CPO-100)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Dec 16, 2022

Ovarian Cancer Trial in United States (Vigil™)

Active, not recruiting
  • Ovarian Cancer
  • Vigil™
  • West Palm Beach, Florida
  • +5 more
Feb 9, 2022